Joseph L. Goldstein received the David Rockefeller Award for Extraordinary Service and honorary degrees were bestowed upon Carolyn Bertozzi and Francis S. Collins.
Gabriel D. Victora's team has turned germinal centers into a living laboratory for one of biology's oldest questions: how much of evolution is shaped by chance?
A new study reveals how germinal centers produce powerful antibodies through noisy rounds of mutation and selection, offering new insight into vaccine design—and larger themes in evolution.
One of the most common drug resistance mutations in tuberculosis creates subtle metabolic weaknesses that could be exploited with future combination therapies.
President Lifton reflects on the university’s long history of innovation, why modern medicine would be unthinkable without basic science, and how the next wave of discoveries will shape the future.
The university’s Research Assistant Association, which holds its third annual poster session on May 20, is designed to build community and skills among its early-career scientists.
Svetlana Mojsov, whose research led to the development of revolutionary obesity drugs, has been promoted. She is now Rockefeller’s Lulu Chow Wang and Robin Chemers Neustein Research Professor.
The brain activity that occurs during the act of drawing reveals fundamental neural properties and has implications for the improvement of brain-computer interfaces and the study of brain disorders.
Two techniques—one for optics-free spatial mapping of tissue organization and the other for the enrichment of rare cell types—offer new ways to study aging and disease.
RNA polymerase, the enzyme that synthesizes RNA from DNA during transcription, has been captured mid-reaction for the first time. The findings provide a universal blueprint for gene expression.
The two scientists are the 35th and 36th members of Rockefeller's current faculty to be honored with membership in the prestigious academy founded by Abraham Lincoln.
The findings, which have implications for cancer and other diseases, resulted from capturing the first snapshot of a mechanical signaling complex in action.
By editing blood stem cells, researchers show that the immune system itself can be transformed into a durable, boostable source of therapeutic proteins—opening the door to novel treatments
Three years in, the Stavros Niarchos Foundation Institute for Global Infectious Disease Research has matured into a working pipeline connecting basic science and emerging therapies.
Researchers created the first mouse model in which chronic viral infection progresses to liver cancer, closely mirroring what happens in people with hepatitis C.
The Rockefeller teams will map immune cell interactions, engineer cells as drug delivery systems, and activate immune responses in hard-to-treat cancers.
Theodora Hatziioannou used her expertise on HIV-1 to gain insights into SARS-Co-V-2, and vice versa. The potential applications of her insights could be much broader.
The Rockefeller University Biotech Club is offering a series of talks, bringing in startup founders and industry experts to share their experience of turning lab discoveries into companies.
